Taste Test of a New Formulation of Sildenafil (Revatio)

Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT00768573
Collaborator
(none)
4
1

Study Details

Study Description

Brief Summary

taste of formulation

Condition or Disease Intervention/Treatment Phase

Detailed Description

taste test None

Study Design

Study Type:
Observational
Actual Enrollment :
4 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
A Single-Blind Study In Healthy Adult Volunteers To Investigate The Palatability Of Different Oral Suspension Formulations Of Revatio®
Study Start Date :
Jan 1, 2008
Actual Primary Completion Date :
Jan 1, 2008
Actual Study Completion Date :
Jan 1, 2008

Arms and Interventions

Arm Intervention/Treatment
1. Taste test

Drug: sildenafil
Oral suspension of sildenafil.

Outcome Measures

Primary Outcome Measures

  1. palatability (aroma, flavour texture and mouth feel) [Duration of study.]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy
Exclusion Criteria:
  • History of hypersensitivity to test compounds or excipients.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pfizer Investigational Site Cambridge Massachusetts United States 02140

Sponsors and Collaborators

  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Investigators

  • Study Director: Pfizer CT.gov Call Center, Pfizer

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
ClinicalTrials.gov Identifier:
NCT00768573
Other Study ID Numbers:
  • A1481257
First Posted:
Oct 8, 2008
Last Update Posted:
Feb 1, 2021
Last Verified:
Jan 1, 2021
Keywords provided by Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 1, 2021